 | • レポートコード：GIR-107A12467 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、医療におけるメタゲノミクスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。医療におけるメタゲノミクスの種類別市場規模（サンプル抽出キット、メタゲノミクスキット）、用途別市場規模（製薬産業、バイオテクノロジー企業、病理学研究所、学術・研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・医療におけるメタゲノミクスの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Illumina、QIAGEN、PerkinElmer、Thermo Fisher Scientific、Oxford Nanopore Technologies ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：サンプル抽出キット、メタゲノミクスキット ・用途別分析2016年-2026年：製薬産業、バイオテクノロジー企業、病理学研究所、学術・研究所、その他 ・医療におけるメタゲノミクスの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・医療におけるメタゲノミクスのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・医療におけるメタゲノミクスのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・医療におけるメタゲノミクスの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・医療におけるメタゲノミクスの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Metagenomics in Healthcare market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Metagenomics in Healthcare size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Metagenomics in Healthcare market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Metagenomics in Healthcare market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Sample Extraction Kits
Metagenomics Kits
Market segment by Application, can be divided into
Pharmaceutical Industries
Biotechnology Companies
Pathology Laboratories
Academic and Research Laboratories
Others
Market segment by players, this report covers
Illumina
QIAGEN
PerkinElmer
Thermo Fisher Scientific
Oxford Nanopore Technologies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Metagenomics in Healthcare
1.2 Classification of Metagenomics in Healthcare by Type
1.2.1 Overview: Global Metagenomics in Healthcare Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Metagenomics in Healthcare Revenue Market Share by Type in 2020
1.2.3 Sample Extraction Kits
1.2.4 Metagenomics Kits
1.3 Global Metagenomics in Healthcare Market by Application
1.3.1 Overview: Global Metagenomics in Healthcare Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Pharmaceutical Industries
1.3.3 Biotechnology Companies
1.3.4 Pathology Laboratories
1.3.5 Academic and Research Laboratories
1.3.6 Others
1.4 Global Metagenomics in Healthcare Market Size & Forecast
1.5 Global Metagenomics in Healthcare Market Size and Forecast by Region
1.5.1 Global Metagenomics in Healthcare Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Metagenomics in Healthcare Market Size by Region, (2016-2021)
1.5.3 North America Metagenomics in Healthcare Market Size and Prospect (2016-2026)
1.5.4 Europe Metagenomics in Healthcare Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Metagenomics in Healthcare Market Size and Prospect (2016-2026)
1.5.6 South America Metagenomics in Healthcare Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Metagenomics in Healthcare Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Metagenomics in Healthcare Market Drivers
1.6.2 Metagenomics in Healthcare Market Restraints
1.6.3 Metagenomics in Healthcare Trends Analysis
2 Company Profiles
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina Metagenomics in Healthcare Product and Solutions
2.1.4 Illumina Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Illumina Recent Developments and Future Plans
2.2 QIAGEN
2.2.1 QIAGEN Details
2.2.2 QIAGEN Major Business
2.2.3 QIAGEN Metagenomics in Healthcare Product and Solutions
2.2.4 QIAGEN Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 QIAGEN Recent Developments and Future Plans
2.3 PerkinElmer
2.3.1 PerkinElmer Details
2.3.2 PerkinElmer Major Business
2.3.3 PerkinElmer Metagenomics in Healthcare Product and Solutions
2.3.4 PerkinElmer Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 PerkinElmer Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Metagenomics in Healthcare Product and Solutions
2.4.4 Thermo Fisher Scientific Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Oxford Nanopore Technologies
2.5.1 Oxford Nanopore Technologies Details
2.5.2 Oxford Nanopore Technologies Major Business
2.5.3 Oxford Nanopore Technologies Metagenomics in Healthcare Product and Solutions
2.5.4 Oxford Nanopore Technologies Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Oxford Nanopore Technologies Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Metagenomics in Healthcare Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Metagenomics in Healthcare Players Market Share
3.2.2 Top 10 Metagenomics in Healthcare Players Market Share
3.2.3 Market Competition Trend
3.3 Metagenomics in Healthcare Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Metagenomics in Healthcare Revenue and Market Share by Type (2016-2021)
4.2 Global Metagenomics in Healthcare Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Metagenomics in Healthcare Revenue Market Share by Application (2016-2021)
5.2 Metagenomics in Healthcare Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Metagenomics in Healthcare Revenue by Type (2016-2026)
6.2 North America Metagenomics in Healthcare Revenue by Application (2016-2026)
6.3 North America Metagenomics in Healthcare Market Size by Country
6.3.1 North America Metagenomics in Healthcare Revenue by Country (2016-2026)
6.3.2 United States Metagenomics in Healthcare Market Size and Forecast (2016-2026)
6.3.3 Canada Metagenomics in Healthcare Market Size and Forecast (2016-2026)
6.3.4 Mexico Metagenomics in Healthcare Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Metagenomics in Healthcare Revenue by Type (2016-2026)
7.2 Europe Metagenomics in Healthcare Revenue by Application (2016-2026)
7.3 Europe Metagenomics in Healthcare Market Size by Country
7.3.1 Europe Metagenomics in Healthcare Revenue by Country (2016-2026)
7.3.2 Germany Metagenomics in Healthcare Market Size and Forecast (2016-2026)
7.3.3 France Metagenomics in Healthcare Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Metagenomics in Healthcare Market Size and Forecast (2016-2026)
7.3.5 Russia Metagenomics in Healthcare Market Size and Forecast (2016-2026)
7.3.6 Italy Metagenomics in Healthcare Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Metagenomics in Healthcare Revenue by Type (2016-2026)
8.2 Asia-Pacific Metagenomics in Healthcare Revenue by Application (2016-2026)
8.3 Asia-Pacific Metagenomics in Healthcare Market Size by Region
8.3.1 Asia-Pacific Metagenomics in Healthcare Revenue by Region (2016-2026)
8.3.2 China Metagenomics in Healthcare Market Size and Forecast (2016-2026)
8.3.3 Japan Metagenomics in Healthcare Market Size and Forecast (2016-2026)
8.3.4 South Korea Metagenomics in Healthcare Market Size and Forecast (2016-2026)
8.3.5 India Metagenomics in Healthcare Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Metagenomics in Healthcare Market Size and Forecast (2016-2026)
8.3.7 Australia Metagenomics in Healthcare Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Metagenomics in Healthcare Revenue by Type (2016-2026)
9.2 South America Metagenomics in Healthcare Revenue by Application (2016-2026)
9.3 South America Metagenomics in Healthcare Market Size by Country
9.3.1 South America Metagenomics in Healthcare Revenue by Country (2016-2026)
9.3.2 Brazil Metagenomics in Healthcare Market Size and Forecast (2016-2026)
9.3.3 Argentina Metagenomics in Healthcare Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Metagenomics in Healthcare Revenue by Type (2016-2026)
10.2 Middle East & Africa Metagenomics in Healthcare Revenue by Application (2016-2026)
10.3 Middle East & Africa Metagenomics in Healthcare Market Size by Country
10.3.1 Middle East & Africa Metagenomics in Healthcare Revenue by Country (2016-2026)
10.3.2 Turkey Metagenomics in Healthcare Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Metagenomics in Healthcare Market Size and Forecast (2016-2026)
10.3.4 UAE Metagenomics in Healthcare Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Metagenomics in Healthcare Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Metagenomics in Healthcare Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Metagenomics in Healthcare Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Metagenomics in Healthcare Revenue (USD Million) by Region (2016-2021)
Table 5. Global Metagenomics in Healthcare Revenue Market Share by Region (2021-2026)
Table 6. Illumina Corporate Information, Head Office, and Major Competitors
Table 7. Illumina Major Business
Table 8. Illumina Metagenomics in Healthcare Product and Solutions
Table 9. Illumina Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 11. QIAGEN Major Business
Table 12. QIAGEN Metagenomics in Healthcare Product and Solutions
Table 13. QIAGEN Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 15. PerkinElmer Major Business
Table 16. PerkinElmer Metagenomics in Healthcare Product and Solutions
Table 17. PerkinElmer Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fisher Scientific Major Business
Table 20. Thermo Fisher Scientific Metagenomics in Healthcare Product and Solutions
Table 21. Thermo Fisher Scientific Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Oxford Nanopore Technologies Corporate Information, Head Office, and Major Competitors
Table 23. Oxford Nanopore Technologies Major Business
Table 24. Oxford Nanopore Technologies Metagenomics in Healthcare Product and Solutions
Table 25. Oxford Nanopore Technologies Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Metagenomics in Healthcare Revenue (USD Million) by Players (2019-2021)
Table 27. Global Metagenomics in Healthcare Revenue Share by Players (2019-2021)
Table 28. Breakdown of Metagenomics in Healthcare by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Metagenomics in Healthcare Players Head Office, Products and Services Provided
Table 30. Metagenomics in Healthcare Mergers & Acquisitions in the Past Five Years
Table 31. Metagenomics in Healthcare New Entrants and Expansion Plans
Table 32. Global Metagenomics in Healthcare Revenue (USD Million) by Type (2016-2021)
Table 33. Global Metagenomics in Healthcare Revenue Share by Type (2016-2021)
Table 34. Global Metagenomics in Healthcare Revenue Forecast by Type (2021-2026)
Table 35. Global Metagenomics in Healthcare Revenue by Application (2016-2021)
Table 36. Global Metagenomics in Healthcare Revenue Forecast by Application (2021-2026)
Table 37. North America Metagenomics in Healthcare Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Metagenomics in Healthcare Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Metagenomics in Healthcare Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Metagenomics in Healthcare Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Metagenomics in Healthcare Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Metagenomics in Healthcare Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Metagenomics in Healthcare Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Metagenomics in Healthcare Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Metagenomics in Healthcare Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Metagenomics in Healthcare Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Metagenomics in Healthcare Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Metagenomics in Healthcare Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Metagenomics in Healthcare Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Metagenomics in Healthcare Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Metagenomics in Healthcare Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Metagenomics in Healthcare Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Metagenomics in Healthcare Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Metagenomics in Healthcare Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Metagenomics in Healthcare Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Metagenomics in Healthcare Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Metagenomics in Healthcare Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Metagenomics in Healthcare Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Metagenomics in Healthcare Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Metagenomics in Healthcare Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Metagenomics in Healthcare Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Metagenomics in Healthcare Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Metagenomics in Healthcare Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Metagenomics in Healthcare Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Metagenomics in Healthcare Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Metagenomics in Healthcare Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Metagenomics in Healthcare Picture
Figure 2. Global Metagenomics in Healthcare Revenue Market Share by Type in 2020
Figure 3. Sample Extraction Kits
Figure 4. Metagenomics Kits
Figure 5. Metagenomics in Healthcare Revenue Market Share by Application in 2020
Figure 6. Pharmaceutical Industries Picture
Figure 7. Biotechnology Companies Picture
Figure 8. Pathology Laboratories Picture
Figure 9. Academic and Research Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Metagenomics in Healthcare Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Metagenomics in Healthcare Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Metagenomics in Healthcare Revenue Market Share by Region (2016-2026)
Figure 14. Global Metagenomics in Healthcare Revenue Market Share by Region in 2020
Figure 15. North America Metagenomics in Healthcare Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Metagenomics in Healthcare Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Metagenomics in Healthcare Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Metagenomics in Healthcare Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Metagenomics in Healthcare Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Metagenomics in Healthcare Market Drivers
Figure 21. Metagenomics in Healthcare Market Restraints
Figure 22. Metagenomics in Healthcare Market Trends
Figure 23. Illumina Recent Developments and Future Plans
Figure 24. QIAGEN Recent Developments and Future Plans
Figure 25. PerkinElmer Recent Developments and Future Plans
Figure 26. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 27. Oxford Nanopore Technologies Recent Developments and Future Plans
Figure 28. Global Metagenomics in Healthcare Revenue Share by Players in 2020
Figure 29. Metagenomics in Healthcare Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Metagenomics in Healthcare Revenue Market Share in 2020
Figure 31. Global Top 10 Players Metagenomics in Healthcare Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Metagenomics in Healthcare Revenue Share by Type in 2020
Figure 34. Global Metagenomics in Healthcare Market Share Forecast by Type (2021-2026)
Figure 35. Global Metagenomics in Healthcare Revenue Share by Application in 2020
Figure 36. Global Metagenomics in Healthcare Market Share Forecast by Application (2021-2026)
Figure 37. North America Metagenomics in Healthcare Sales Market Share by Type (2016-2026)
Figure 38. North America Metagenomics in Healthcare Sales Market Share by Application (2016-2026)
Figure 39. North America Metagenomics in Healthcare Revenue Market Share by Country (2016-2026)
Figure 40. United States Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Metagenomics in Healthcare Sales Market Share by Type (2016-2026)
Figure 44. Europe Metagenomics in Healthcare Sales Market Share by Application (2016-2026)
Figure 45. Europe Metagenomics in Healthcare Revenue Market Share by Country (2016-2026)
Figure 46. Germany Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Metagenomics in Healthcare Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Metagenomics in Healthcare Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Metagenomics in Healthcare Revenue Market Share by Region (2016-2026)
Figure 54. China Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Metagenomics in Healthcare Sales Market Share by Type (2016-2026)
Figure 61. South America Metagenomics in Healthcare Sales Market Share by Application (2016-2026)
Figure 62. South America Metagenomics in Healthcare Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Metagenomics in Healthcare Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Metagenomics in Healthcare Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Metagenomics in Healthcare Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source
世界のヘルスケアにおけるメタゲノム市場予測（～2024年） Metagenomics is the study of genetic material recovered directly from environmental samples. Scope of the Report: The global Metagenomics in Healthcare market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 202…- 世界の医療における液体クロマトグラフィー市場 2021：企業別、地域別、種類・用途別 The Liquid Chromatography in Healthcare market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 世界の女性医療市場 2021：企業別、地域別、種類・用途別 The Women Healthcare market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 世界のサルコペニア医療市場 2021：企業別、地域別、種類・用途別 The Sarcopenia Healthcare market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の医療用AI市場 2021：企業別、地域別、種類・用途別 The Healthcare AI market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…